… ProQR Announces Management Change and Key Promotions Key Updates Company announces departure of Noreen R. Henig, Chief Medical Officer, promotion of Peter Adamson … M.D. “It’s been a privilege to work with the talent inside ProQR, as well as the investigators and scientific …
… ProQR Announces Virtual Presentations at Scientific … Meeting of the American Academy of Optometry (AAOpt). ProQR’s presentation at Ophthalmology Futures Retina Forum … Leber congenital amaurosis 10 (LCA10) Presenter: Stephen R. Russell, MD, principal investigator of the ProQR Phase 1/2 …
… ProQR to Present at Upcoming Scientific Conferences … Mass., Nov. 18, 2019 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq:PRQR), a company dedicated to … be delivered by Aniz Girach, MD, Chief Medical Officer of ProQR, during the 3 rd Annual Ophthalmic Drugs Conference to …
… ProQR to Present at Upcoming Investor Conference LEIDEN, the … at 12:00 pm PT, Smital Shah, Chief Financial Officer of ProQR, will present at the 30 th Annual Roth Conference. The … be accessible from the ‘Investor Relations’ section of ProQR’s website ( www.proqr.com ) under ‘Events and …
… ProQR Announces Virtual Presentation at EURETINA 2021 LEIDEN, … & CAMBRIDGE, Mass., Sept. 06, 2021 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq:PRQR), a company dedicated to … on the EURETINA platform at the start of the congress. ProQR’s Presentation Title: Phase 1b/2 interim results of …
… ProQR Announces Expert Perspectives Conference Call Series … & CAMBRIDGE, Mass., June 12, 2020 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq:PRQR), a company dedicated to … Drs. Girach and Koenekoop will also discuss QR-421a, ProQR’s investigational therapy for patients with Usher …
… ProQR to Present at Upcoming Investor Conferences … Mass., Nov. 13, 2019 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq:PRQR), a company dedicated to … will be accessible from the ‘Investors’ section of ProQR’s website ( www.proqr.com ) under ‘Events and Presentations’. The …
… ProQR Announces Extraordinary General Meeting of Shareholders … be made available in the ‘Investor Relations’section of ProQR’s website ( www.proqr.com ) under ‘Financial Information’. The documents …
LEIDEN, Netherlands, Sept. 18, 2014 (GLOBE NEWSWIRE) -- ProQR Therapeutics today announced the pricing of its initial public offering of 7,500,000 ordinary shares at an initial public offering price of $13.00 per ordinary share.
… ProQR to Present at Two Upcoming Conferences LEIDEN, the Netherlands, April 03, 2018 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq:PRQR), a company dedicated to … at 9:25 am CET, Daniel de Boer, Chief Executive Officer of ProQR, will present at the H.C. Wainwright Global Life …